The Value of Chemokine and Chemokine Receptors in Diagnosis, Prognosis, and Immunotherapy of Hepatocellular Carcinoma.
Zhengyi WuLiang SunYongkang XuHe HuangZhipeng WuBingbing QiuJinlong YanXiangbao YinPublished in: Cancer management and research (2024)
The CCRs-related gene signature may better assess HCC prognosis and response to immunotherapy and tyrosine kinase inhibitors such as sorafenib in HCC, providing prospective solutions for diagnosis and treatment.